Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Winn

Showing results (211-220 of 414) with videos related to

Pageof 42
Sort By:
Journal of Medicinal Chemistry|November 2, 2001
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 5. Highly selective, potent, and orally active ET(A) antagonistsH S Jae, M Winn, T W von Geldern, et al.
American Journal of Preventive Medicine|May 25, 2010
Bioinformatics: Tools to accelerate population science and disease control researchMichele R Forman, Sarah M Greene, Nancy E Avis, et al.
Journal of Medicinal Chemistry|October 2, 1992
Discovery of a novel class of orally active, non-peptide angiotensin II antagonistsB De, M Winn, T M Zydowsky, et al.
Journal of Occupational and Environmental Medicine|August 14, 2003
Sugarcane farming, occupational solvent exposures, and the risk of oral cancer in Puerto RicoJoseph B Coble, Linda Morris Brown, Richard B Hayes, et al.
Journal of Medicinal Chemistry|October 1, 1985
Conformationally defined adrenergic agents. 1. Design and synthesis of novel alpha 2 selective adrenergic agents: electrostatic repulsion based conformational prototypesJ F DeBernardis, D J Kerkman, M Winn, et al.
American Journal of Epidemiology|May 15, 2003
Alcohol concentration and risk of oral cancer in Puerto RicoWen-Yi Huang, Deborah M Winn, Linda M Brown, et al.
Oncogene|April 13, 2021
Aberrant CREB1 activation in prostate cancer disrupts normal prostate luminal cell differentiationM J Watson, P L Berger, K Banerjee, et al.
Cancer|October 12, 2001
Family cancer history and susceptibility to oral carcinoma in Puerto RicoL M Brown, G Gridley, S R Diehl, et al.
The Journal of Nutrition|April 2, 2002
Folate intake, serum homocysteine and methylenetetrahydrofolate reductase (MTHFR) C677T genotype are not associated with oral cancer risk in Puerto RicoStephanie J Weinstein, Gloria Gridley, Lea C Harty, et al.
MMWR. Morbidity and Mortality Weekly Report|November 11, 2016
Vital Signs: Disparities in Tobacco-Related Cancer Incidence and Mortality - United States, 2004-2013S Jane Henley, Cheryll C Thomas, Saida R Sharapova, et al.
Pageof 42

Showing results (211-220 of 414) with videos related to

Sort By:
Pageof 42
Journal of Medicinal Chemistry|November 2, 2001
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 5. Highly selective, potent, and orally active ET(A) antagonistsH S Jae, M Winn, T W von Geldern, et al.
American Journal of Preventive Medicine|May 25, 2010
Bioinformatics: Tools to accelerate population science and disease control researchMichele R Forman, Sarah M Greene, Nancy E Avis, et al.
Journal of Medicinal Chemistry|October 2, 1992
Discovery of a novel class of orally active, non-peptide angiotensin II antagonistsB De, M Winn, T M Zydowsky, et al.
Journal of Occupational and Environmental Medicine|August 14, 2003
Sugarcane farming, occupational solvent exposures, and the risk of oral cancer in Puerto RicoJoseph B Coble, Linda Morris Brown, Richard B Hayes, et al.
Journal of Medicinal Chemistry|October 1, 1985
Conformationally defined adrenergic agents. 1. Design and synthesis of novel alpha 2 selective adrenergic agents: electrostatic repulsion based conformational prototypesJ F DeBernardis, D J Kerkman, M Winn, et al.
American Journal of Epidemiology|May 15, 2003
Alcohol concentration and risk of oral cancer in Puerto RicoWen-Yi Huang, Deborah M Winn, Linda M Brown, et al.
Oncogene|April 13, 2021
Aberrant CREB1 activation in prostate cancer disrupts normal prostate luminal cell differentiationM J Watson, P L Berger, K Banerjee, et al.
Cancer|October 12, 2001
Family cancer history and susceptibility to oral carcinoma in Puerto RicoL M Brown, G Gridley, S R Diehl, et al.
The Journal of Nutrition|April 2, 2002
Folate intake, serum homocysteine and methylenetetrahydrofolate reductase (MTHFR) C677T genotype are not associated with oral cancer risk in Puerto RicoStephanie J Weinstein, Gloria Gridley, Lea C Harty, et al.
MMWR. Morbidity and Mortality Weekly Report|November 11, 2016
Vital Signs: Disparities in Tobacco-Related Cancer Incidence and Mortality - United States, 2004-2013S Jane Henley, Cheryll C Thomas, Saida R Sharapova, et al.
Pageof 42